Can obese patients benefit from the Coronary CTA pathway to diagnose Coronary Artery Disease?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Can obese patients benefit from the Coronary CTA pathway to diagnose Coronary Artery Disease?

By HeartFlow FEATURING Maros Ferencik

1,177 views

September 6, 2024

Dr. Maros Ferencik reviews insights from the PRECISE Trial sub study evaluating the difference in test results and outcomes between obese and non-obese patients using a usual testing strategy or coronary computed tomography (CCTA) with selective noninvasive fractional flow reserve (FFRCT).

Comments 0